Belgium· BE-AMP-SAM660838-00
Teriflunomide Viatris 14 mg
A teriflunomide product containing teriflunomide, registered in Belgium by Mylan Pharmaceuticals. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Teriflunomide is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AK02 (teriflunomide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Teriflunomide · ATC L04AK02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of teriflunomide costs, country by country.
Normalised to the WHO defined daily dose (14 mg), the median price runs from $18.33 in Switzerland to $28.01 in Italy — a ×1.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Teriflunomide · price per daily dose (14 mg)
USD · FX 28 Sept 2026
- IT Italy$28.01
- CH Switzerland$18.33
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Teriflunomide
- Manufacturer
- Mylan Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- L04AK02
- ATC class
- Teriflunomide
- Defined daily dose
- 14 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb4638144EUR 313.04
- be_apb4638151EUR 722.32
- be_apb7737844
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
668 interactions on record for teriflunomide.
Graded by severity as the source publishes them — 542 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Teriflunomide · interactions on record
668 records
- 542 severe
- 116 moderate
- 10 minor
Most severe, free to view
- ClotrimazoleA01AB18severe
- Chenodeoxycholic acidA05AA01severe
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Teriflunomide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAREGALUKrka, d.d., Novo mesto, Novo mesto
- PolandAregaluKrka, d.d., Novo mesto
- SpainAUBAGIO 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULASanofi Winthrop Industrie
- SwitzerlandAubagio
- FinlandAubagioAbacus Medicine A/S
- IcelandAUBAGIOSanofi Winthrop Industrie
- SwedenAUBAGIO 14 mg Filmdragerad tablettSanofi Winthrop Industrie
- United StatesAubagioGenzyme Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Terebyo, Teriflunomid +pharma
- Bulgaria · Terebyo, Teriflunomide Msn
- Cyprus · Aregalu, Arogio
- Czechia · Aregalu, Boxarid
- Germany · Terebyo, Teriflago
- Denmark · Clefirem, Teriflunomid Devatis
- Estonia · Aregalu, Boxarid
- Spain · Clefirem, Teriflunomida Aurovitas
- Finland · Clefirem, Teriflunomide Avansor
- France · Terebyo, Teriflunomide Arrow
- United Kingdom (Northern Ireland) · Teriflunomide, Teriflunomide Abdi
- Greece · Aregalu, Arogio
- Croatia · Aregalu, Telirem
- Hungary · Aregalu, Arogio
- Ireland · Teriflunomide Clonmel
- Iceland · Aubagio, Feple
- Italy · Clefirem, Terebyo
- Liechtenstein · Aubagio, Teriflunomide Accord
- Lithuania · Aregalu, Boxarid
- Luxembourg · Teriflunomide Eg, Teriflunomide Eg (Eurogenerics)
- Latvia · Aregalu, Boxarid
- Malta · Telirem, Tergio
- Netherlands · Teriflox, Teriflunomide Abdi
- Norway · Aubagio, Clefirem
- Poland · Aregalu, Boxarid
- Portugal · Teriflunomida Basi, Teriflunomida Bluepharma
- Romania · Aregalu, Boxarid
- Sweden · Clefirem, Teriflunomid Devatis
- Slovenia · Aregalu, Clefirem
- Slovakia · Aregalu, Boxarid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9d5cd75-20af-4953-8934-4d0119d87845 GET /v1/drugs/d9d5cd75-20af-4953-8934-4d0119d87845?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Teriflunomide Viatris 14 mg",
"name_fr": "Tériflunomide Viatris 14 mg",
"name_nl": "Teriflunomide Viatris 14 mg",
"amp_code": "SAM660838-00",
"strengths": [
"14.0000",
"14.0000",
"14.0000",
"85.4000"
],
"pack_count": 13,
"substances": [
"Teriflunomide",
"Lactose",
"Sodium Starch Glycolate (Type A)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Teriflunomide",
"authorisation_numbers": [
"EU/1/22/1698/007",
"EU/1/22/1698/002",
"EU/1/22/1698/001",
"EU/1/22/1698/005",
"EU/1/22/1698/003",
"EU/1/22/1698/004",
"EU/1/22/1698/006",
"EU/1/22/1698/012",
"EU/1/22/1698/013",
"EU/1/22/1698/008",
"EU/1/22/1698/010",
"EU/1/22/1698/009",
"EU/1/22/1698/011"
]
}See everything about teriflunomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.